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Heparin inhibited the dephosphorylation of rabbit skeletal muscle or liver phosphorylase a by protein 
phosphatase-1 . Other glycosaminoglycans (chondroitin sulfates) and their constituents were found to be 
without effect. The chromatography of a partially purified phosphatase preparation on 
heparin-Sepharose CL-6B resulted in a fraction that did not bind to the matrix and its activity was not 
inhibited by heparin or inhibitor-l. The phosphatase bound to heparin-Sepharose was eluted by 0.2 M 
NaCl and was inhibited by heparin or inhibitor-l. 
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1. INTRODUCTION [lO,ll], whereas it increases the activity of 
phosphorylase kinase [ 12,131. 
Protein phosphatases (EC 3.1.3. _ ) catalyze the 
dephosphorylation of various phosphoproteins, 
and for this reason, there has been much interest in 
the control of their activity. A very large number 
of phosphatase activities have been described and 
the nature of phosphatases has been a subject of 
controversy. It seems that two classes of the en- 
zymes, termed phosphatase-1 and -2, account for 
virtually all of the phosphatase activity [1,2]. The 
dephosphorylation reactions are important 
regulatory devices of glycogen metabolism. The 
activity of phosphorylase a (EC 2.4.1.1) is con- 
trolled by reversible phosphorylation of a serine 
residue. Ligands and proteins can influence the 
rate of dephosphorylation with the modification of 
phosphorylase a (for references, see [3-61). 
We have reported that heparin stimulates the ac- 
tivity of skeletal muscle and liver phosphorylase 
kinase in a Ca’+-dependent manner [ 141. We here 
report the complete inhibition of protein 
phosphatase-1 by heparin. The purification of 
phosphatase-1 by chromatography on heparin- 
Sepharose suggests an interaction between the 
enzyme and heparin. 
2. MATERIALS AND METHODS 
Chondroitin sulfates, glucose derivatives and 
SDS MI marker proteins were purchased from 
Sigma, heparin from Serva and heparin- 
Sepharose CLdB from Pharmacia. Other chemi- 
cals used were analytical grade. 
Also of current interest are two heat-stable pro- Protein phosphatase-1 was isolated from rabbit 
tein inhibitors of phosphatase activity. Inhibitor-l muscle [15] as modified in [8]. Liver protein 
is active only after phosphorylation by CAMP- phosphatase was prepared as in [16]. The activity 
dependent protein kinase [7] and inhibitor-2 is a of both preparations was inhibited by inhibitor-l 
constituent of MgATP-dependent phosphatase [8]. therefore they are considered as phosphatase-1. 
Both are specific inhibitors of phosphatase-1 Purification and phosphorylation of inhibitor-l 
although they do not interact with the enzyme in were done as in [7]. Rabbit muscle 32P-labelled 
an identical manner [9]. Heparin, a sulfated phosphorylase a and liver phosphorylase a were 
polysaccharide, inhibits some protein kinases prepared as in [6] and [17], respectively. 
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Phosphorylated glycogen synthase was prepared 
from rabbit muscle [18]. Protein was determined 
as in [19]. 
2.1. Assay of protein phosphatase 
The reactions were carried out at 30°C in 40 mM 
Tris (pH 7.4) and 10 mM ,&mercaptoethanol buf- 
fer using 1 mg/ml 32P-labelled phosphosubstrates. 
Heparin, inhibitor-l or other effecters tested were 
preincubated with phosphatase for 5 min and the 
reaction was started by the addition of 
phosphosubstrates. The liberation of [32P]or- 
thophosphate was followed as in [5]. One unit of 
phosphatase activity is defined as 1 nmol 
phosphate liberated per min under the assay condi- 
tions [8]. 
3. RESULTS 
The dephosphorylation of muscle and liver 
phosphorylase a was inhibited by increasing con- 
centration of heparin in an identical manner 
(fig.1). Five to ten pug/ml of heparin caused 50% 
inhibition of the dephosphorylation reaction. Fur- 
thermore, the heparin inhibition was independent 
of the origin of phosphatase. Heparin also in- 
hibited the dephosphorylation of glycogen syn- 
thase by muscle phosphatase-1 (not shown). 
Chondroitin sulfate A and C even in lo-fold 
higher concentrations than heparin were ineffec- 
tive in inhibiting phosphatase activity. Monosac- 
charide constituents of glycosaminoglycans were 
also tested and found to be without effect (table 1). 
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Fig. 1. Effect of heparin on the activities of muscle and 
liver protein phosphatases. Activities of muscle 
phosphatase-1 (A) and liver phosphatase-1 (B) were 
assayed with muscle (0) or liver (A) phosphorylase a. 
Table 1 
The effects of glycosaminoglycans and glucose 
derivatives on phosphorylase phosphatase activity 
Effector Phosphatase 
activity (070) 
None 100 
10 pg/ml heparin 34 
100 pg/ml chondroitin sulfate A 94 
100 pg/ml chondroitin sulfate C 91 
10 mM glucosamine 95 
10 mM glucuronic acid 96 
10 mM Na-sulfate 64 
Dephosphorylation of muscle phosphorylase a by 
muscle protein phosphatase-1 was carried out in the 
presence of the listed ligands. The means of 3 
experiments are shown (SD f 5%) 
0 0 16 24 32 
Fraction number 
Fig.2. Chromatography of protein phosphatase on 
heparin-Sepharose. Partially purified muscle protein 
phosphatase preparation [8], material from step 4 
(DEAE-cellulose), was subjected to chromatography on 
heparin-Sepharose CL-6B. Protein (1.4 mg) was 
applied to the column (1.2 x 5 cm) equilibrated in 
20 mM Tris (pH 7.4), 10 mM ,&mercaptoethanol, 0.1 M 
EGTA (buffer A). The column was washed with buffer 
A and a linear gradient (80 ml) of O-O.5 M NaCl in 
buffer A was developed beginning at fraction 10. The 
flow rate was 12 ml/h and fractions of 2 ml were 
collected. Fractions were assayed for phosphatase 
activity (0) with 32P-labelled phosphorylase a and for 
protein (0). Inset: electrophoresis of peak II on 10% 
polyacrylamide gels in the presence of SDS [20]. (a) 
Protein (4 pg) of peak II; (b) M, standards. 
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Table 2 4. DISCUSSION 
Effect of heparin and inhibitor-l on the activity of 
phosphatase before and after heparin-Sepharose 
chromatography 
Our results show that the inhibition of 
phosphatase-1 by heparin is complete and not 
mimicked by closely related polysaccnarides. The 
inhibition was also observed by using alternative 
phosphosubstrates (muscle or liver phosphorylase 
and synthase) suggesting that heparin acts directly 
on phosphatase-1. The latter was also supported 
by chromatography on heparin-Sepharose. This 
single step resolved two phosphatases and the 
specific activity of matrix-bound enzyme was in- 
creased 20-30-fold. Therefore heparin-Sepharose 
is a useful tool in the purification of phosphatase-1 
and in the separation of phosphatase-1 from 
phosphatase-2. It seems that heparin is able to 
distinguish between the two types of phosphatases 
as can the heat-stable inhibitors. This raises the 
possibility that the negative charges of heparin 
may cause its inhibitory property since an acidic 
region (residues 42-54) of inhibitor-l may also be 
essential [21]. 
Effector Specific activity of 
phosphatase (units/mg) 
Starting 
material 
Heparin- 
epharosea 
Peak I Peak II 
None 1080 490 26400 
+ lOpg/ml heparin 626 473 11090 
+ 50 pug/ml heparin 305 451 1680 
+ 1 /rg/ml inhibitor-l 268 460 2544 
a Peak II accounted for 70-80% of the total 
phosphatase activity applied to the column and the 
remaining 20-30% of the activity was contributed by 
peak I 
Phosphatase activities were assayed with muscle 
phosphorylase a. Values are the average of 5 
preparations 
Sulfate ions caused an inhibition of phosphatase at 
a high concentration. 
The interaction of heparin with phosphatase was 
also supported by chromatography. It was 
demonstrated that purified muscle phosphatase-1 
was completely adsorbed to heparin-Sepharose 
and eluted by NaCl (not shown). A partially 
purified preparation of muscle phosphatase was 
also loaded on a heparin-Sepharose column and 
eluted by a linear gradient of NaCl (fig.2). Two 
peaks of phosphatase were resolved since 
phosphatase activities appeared in the washing 
buffer (peak I) and another enzyme eluted at 
180-200 mM NaCl (peak II). It is seen that the 
phosphatase activity of peak I was not inhibited by 
either heparin or inhibitor-l (table 2) suggesting 
the presence of phosphatase-2. The enzyme in peak 
II was inhibited by heparin. Inhibitor-l also in- 
hibited the activity of this peak proving that only 
phosphatase-1 can bind to the immobilized 
heparin. The gel electrophoretic pattern of peak II 
showed a major protein band with an A4, of 33ooO 
and a less intense band of higher M, (inset, fig.2). 
Experiments are in progress to determine the 
precise mode of action of heparin and to extend 
the application of heparin-Sepharose for the 
purification of phosphatase-1 of high M, (where 
ethanol treatment is omitted). 
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